US clinical guidelines from organizations such as the American Diabetes Association (ADA), American Gastroenterological Association (AGA), and Endocrine Society recommend continuing effective anti-obesity medication therapy as long as it remains beneficial, well-tolerated, and medically appropriate
This plan delivers several meals every 2-4 weeks, enough for two a day
Ongoing Monitoring Regular check-ins allow us to assess your progress, make dose adjustments if needed, and provide ongoing coaching and support for nutrition, behavior, and lifestyle changes
other notable risks include dehydration, modest heart rate increases, hypoglycaemia, and gallbladder problems
Schedule flexibility: Understand how injection timing shifts affect plasma concentrations for travel or lifestyle adjustments
Both are given as weekly injections via pre-filled pens self-administered into the upper arm, thigh or stomach